- Home
- BOLT vs TRIB Comparison
BOLT vs TRIB Comparison
Compare BOLT & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOLT | TRIB |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 18.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BOLT | TRIB |
|---|---|---|
| Price | $5.36 | $0.82 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 31.5K | ★ 9.2M |
| Earning Date | 11-12-2025 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,195,000.00 | ★ $49,409,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.41 | $0.48 |
| 52 Week High | $12.60 | $3.44 |
Technical Indicators
Market Signals| Indicator | BOLT | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 42.42 |
| Support Level | $5.00 | $0.99 |
| Resistance Level | $5.71 | $1.75 |
| Average True Range (ATR) | 0.39 | 0.17 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 26.96 | 2.34 |
Price Performance
Historical ComparisonAbout BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.